67 results
S-3ASR
EX-1.2
BEAM
Beam Therapeutics Inc
27 Feb 24
Automatic shelf registration
6:10pm
, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
to develop life-long, curative, precision genetic medicines for patients through base editing, including potential safety advantages, all of which … program in the U.S., accelerating path to SCD patients and the market BEACON Phase 1/2 Study Design Select safety endpoints Proportion of patients
8-K
EX-99.2
9ebta
8 Jan 24
Results of Operations and Financial Condition
6:55am
8-K
EX-99.1
7fqnfdcdl yod
8 Nov 23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
kajvvmm ia
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
8-K
EX-99.1
x0we5a dzpl
8 Aug 23
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
7:11am
424B5
3ssmmti
10 May 23
Prospectus supplement for primary offering
5:10pm
8-K
EX-99.1
aw5mzyfx rg5
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
beyytv0ts57z
9 Aug 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
2wpzl9
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am